Navigation Links
Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
Date:5/26/2009

BETHESDA, Md., May 26 /PRNewswire-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYSE: HGR) is pleased to announce that to date in 2009, it has acquired Northwest Prosthetic & Orthotic Clinic and Inline Orthotic and Prosthetic Systems. These acquisitions add patient care centers to existing markets in Washington and California.

President and CEO, Thomas F. Kirk stated, "We are very pleased welcome the talented professionals from both Northwest and Inline to the Hanger team. These acquisitions continue our strategy of building share in existing markets and add value in our core O&P business."

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 675 patient care centers in 45 states and the District of Columbia, with over 3,500 employees including 1,083 practitioners (as of March 31, 2009). Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more information on Innovative Neurotronics, Inc. or the WalkAide(R), visit http://www.ininc.us. For more information on Hanger, visit '/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
2. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
3. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
4. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
5. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
6. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
7. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
8. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide
9. Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008
10. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
11. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Moodys Investors Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... have made a discovery that turns 160 years of ... material long known to be essential for the fast ... is not as ubiquitous as thought, according to a ... Harvard Stem Cell Institute (HSCI) and the University,s Department ... Professor Jeff Lichtman, of Harvard,s Department of Molecular and ...
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... of chronic inflammation in non-cancerous prostate tissue may have ... than those with no inflammation, according to results of ... Hopkins Kimmel Cancer Center. , The link between persistent ... so-called high-grade prostate cancer those with a Gleason ... of the most aggressive and rapidly growing prostate cancers. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2
... IRVING, Texas, Dec. 13 Allarae Healthcare,Inc. (Pink Sheets: ... with Intellect, Inc. to sell their entire product line ... broad range,of personal health testing kits, several already FDA ... kits are ready for market but have,not yet been ...
... as Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA ... the completion of a new network,infrastructure to support a ... and Thurrock University Hospitals, part,of the NHS Foundation Trust ...
... shouldn,t feel like,getting your teeth drilled, according to Mirabai ... industry. For anyone who,s vowed to,start exercising in the ... help them get going. Recently released on DVD, the ... exercise,going at their own pace, so they,re more likely ...
... and females in order to alleviate back pressure from ... spearheaded at The University of Texas at Austin. , ... in the Dec. 13 issue of Nature. , The ... million years ago, in the early human ancestor Australopithecus. ...
... to allowing us to see, the mammalian eye also detects ... of this is the timing of the sleep/wake cycle, which ... pacemaker in the hypothalamus. , In a study published ... two totally blind humans whose non-visual responses to light remain ...
... 13 PARI,s eFlow, an advanced,electronic nebulizer, was ... Phase I human clinical trial. Results of the ... Annual Drug Delivery to the Lungs meeting held,in ... developed as a,treatment for respiratory syncytial virus (RSV) ...
Cached Medicine News:Health News:Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc. 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2Health News:Adapting to pregnancy played key role in human evolution, study shows 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3Health News:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study 2
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle. Designated most popular model or size....
8 mm curved blade. Cutting edge on inside of curve. Flat handle....
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size....
Medicine Products: